Now able to sell abortion pill, U.S. pharmacies weigh if they should
Send a link to a friend
[January 06, 2023]
By Ahmed Aboulenein, Gabriella Borter and Michael Erman
(Reuters) - Pharmacies across the United States are weighing whether to
sell mifepristone, a pill used in medication abortions, following the
Food and Drug Administration's announcement earlier this week that they
can now do so.
What they decide is primarily based on where they are located given that
almost half the states ban or restrict abortion after the Supreme Court
overturned its landmark Roe v Wade ruling, though some pharmacists told
Reuters the local culture and attitudes or their own personal beliefs on
abortion is what guides them.
The FDA rule will make medication abortion, which accounts for more than
half of U.S. abortions, more accessible in states where abortion remains
legal, but its impact on pharmacies in the states that have banned
abortion remains to be seen.
Bill Patel, who has owned Care Rite Pharmacy in Marianna, Florida, for
five years, said he would not seek out certification to dispense
mifepristone at his pharmacy because he is personally opposed to
abortion. The pharmacy is located near Florida's borders with Georgia
and Alabama, where abortion is severely restricted.
He said he would only do it if asked by the health department. "I just
oppose it to be honest with you," he said. "I'm against abortion."
Florida currently bans abortion after 15 weeks and has several other
restrictions.
National pharmacy chain giants Walgreens Boot Alliance Inc and CVS
Health Corp have said they plan to offer mifepristone in states where it
is allowed. Other national and regional chains including Southeastern
Grocers Inc, which owns Winn-Dixie stores, said they are still
considering if they will offer it and where.
A spokesperson for GenBioPro, one of two companies that make
mifepristone in the United States, said the drugmaker has already
started to receive applications for certification but did not provide
further details.
Michelle Vargas, owner of independent Lamar Family Pharmacy in Lamar,
South Carolina, said she is not considering dispensing it.
[to top of second column]
|
Pharmacist Steve Moore works at Condo
Pharmacy in Plattsburgh, New York, U.S., January 5, 2023. Courtesy
of Steve Moore/Handout via REUTERS
"We're in a very small rural area.
We're not near an abortion clinic or in a larger city where that
happens more," she said. "That's just not something we see here."
Legal questions are swirling around the prospects of a drug with FDA
approval being made illegal under state law in some parts of the
country.
With the legal issue unsettled, pharmacies in
states restricting abortion are likely to face legal risks and could
lose their licenses if they decide to sell mifepristone in violation
of state laws, said American Pharmacist Association interim CEO
Ilisa Bernstein, who worked at the FDA for 30 years.
Other factors, such as safety for pharmacies and pharmacists, are
also at play, said Bernstein.
Steve Moore, pharmacist and owner of Condo Pharmacy in Plattsburgh,
New York, a state where abortion is legal, plans to dispense the
drug.
"As far as my role as a pharmacist, I feel it's to help people
safely and effectively use the medications," said Moore. "I'm not in
the role of limiting access to medication."
"We've had patients give us a hard time for dispensing the morning
after pill or birth control. That's certainly your prerogative. But
if that's a concern, then we're not the pharmacy for you, because
we're certainly not going to stop doing that," he said.
Read more:
South Carolina's top court strikes down six-week abortion ban
U.S. FDA changes Plan B label to say it does not cause abortion
(Reporting by Ahmed Aboulenein and Gabriella Borter in Washington,
Michael Erman in New York; Editing by Caroline Humer and Lisa
Shumaker)
[© 2023 Thomson Reuters. All rights
reserved.]This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |